RxDoctor Payments Data

Peter McNally

Gastroenterology · Ft Carson, CONPI 1013987965

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $928,950 of the $1,102,902 with a category attached, or 84.2%. 12 manufacturers reported payments, led by Takeda Pharmaceuticals U.S.A., Inc. at 28.2% of the total. Among gastroenterology clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,102,902in general payments, 2019–2025

Across 628 payments — averaging $1756.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$311K
  • Johnson & Johnson$277K
  • Pfizer$196K
  • Janssen Scientific Affairs, LLC$120K
  • E.r. Squibb & Sons, L.L.C.$106K
  • Madrigal Pharmaceuticals$28K
  • plus $65K from 6 others

What the payments were for

  • Consulting fees$9,0481%
  • Speaking & faculty fees$928,95084%
  • Travel & lodging$159,07914%
  • Food & beverage$5,8211%
  • Education$40%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,102,902 in reported general payments places this provider in the 95th percentile of 304 gastroenterology providers in Colorado.

See all gastroenterology providers in Colorado

Other gastroenterology in Ft Carson

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →